Combined bone scintigraphy and fluorocholine PET/computed tomography predicts response to radium-223 therapy in patients with prostate cancer

Combined bone scintigraphy and fluorocholine PET/computed tomography predicts response to radium-223 therapy in patients with prostate cancer

Aim: To assess the value of bone scintigraphy and 18F-fluorocholine PET/computed tomography (CT) in predicting outcome in patients with prostate cancer and bone metastases treated with 223radium. Materials & methods: Retrospective analysis of 48 patients that underwent 223radium therapy. End poi...

Full description

Saved in:
Bibliographic Details
Main Authors: Michele Klain, Valeria Gaudieri, Mario Petretta, Emilia Zampella, Giovanni Storto, Carmela Nappi, Carlo Buonerba, Felice Crocetto, Rosj Gallicchio, Fabio Volpe, Leonardo Pace, Martin Schlumberger, Alberto Cuocolo
Format: Article
Language:English
Published: Taylor & Francis Group 2021-09-01
Series:Future Science OA
Subjects:
18F-fluorocholine PET/CT outcome
223radium
bone scintigraphy
prostate cancer
Online Access:https://www.future-science.com/doi/10.2144/fsoa-2021-0053
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.future-science.com/doi/10.2144/fsoa-2021-0053

Similar Items